FINWIRES · TerminalLIVE
FINWIRES

Home Depot to Benefit From Professional Demand More than Lowe's in Q2, BofA Says

By

Home Depot's (HD) higher exposure to professional customers is expected to benefit it in Q2 more than Lowe's (LOW), BofA Securities said in a Monday note previewing the upcoming earnings of home improvement retailers.

Based on aggregated spending data from Bank of America (BAC) credit and debit cards, spending on housing-related services, which BofA analysts used as a proxy for professional customer spending, continues to be higher than spending by do-it-yourself customers, and Housing-related services spending grew 5.5% in Q2 from 4% in the previous quarter, while home-improvement spending swung to 0.5% from negative 0.9% in the prior quarter, according to the note.

Home Depot's Pro heavy business model should drive outperformance in Q2, and help it attain 2026 EPS near the midpoint of its guidance, the analysts said. Lowe's (LOW) is seen finishing the year at the lower end of its EPS outlook, given a downside risk to its margins in H2 if higher promotional rates are needed to attract customers.

Further, the two companies are expected to use tariff refunds to help absorb supply chain costs, as well as potentially support promotions costs, the analysts said.

BofA reiterated Home Depot's stock rating at buy and increased the price target to $412 from $374. The brokerage also reiterated Lowe's stock rating at neutral and lowered the price target to $256 from $257.

Price: $349.32, Change: $-6.30, Percent Change: -1.77%

Related Articles

Wire

GRAIL's Galleri Blood Test to Be Evaluated by US FDA Advisory Panel

GRAIL (GRAL) said Friday that an advisory panel of the US Food and Drug Administration will convene on Sept. 23 to evaluate the premarket approval application for its Galleri multi-cancer early detection blood test.The firm submitted the marketing application Jan. 29, incorporating trial results from 25,490 participants in its PATHFINDER 2 study along with over 70,000 subjects from its NHS-Galleri trial, the company said.Shares of the company were up about 8.9% in Friday trading.Price: $69.03, Change: $+5.63, Percent Change: +8.88%

$GRAL
Wire

Top Cryptocurrencies Rise; Bitcoin Holds Above $64,000

Major digital assets rose Friday with Bitcoin (BTC-USD) still holding above $64,000.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 0.3% in the past 24 hours. The Nasdaq 100 added 1.3%, the S&P 500 gained 0.6%, and the Dow Jones Industrial Average increased 0.2%.Bitcoin gained 0.9% to $64,938, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose almost 11% to $21.65 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, rose 0.6% to $1,918.XRP (XRP-USD) fell 1.1%, BNB (BNB-USD) increased 0.5%, and Solana (SOL-USD) rose 1.5%. Dogecoin (DOGE-USD) added 1.6%, while Cardano (ADA-USD) dropped 0.8%.The total market value of the cryptocurrency industry rose 0.6% in the past 24 hours to $2.21 trillion, with trading volume rising 5.3% to $55.6 billion.Price: $64913.74, Change: $+654.06, Percent Change: +1.02%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Celestica Completes $3.45 Billion Equity Offering

Celestica (CLS) said Friday it completed a $3.45 billion equity offering through the sale of about 11.1 million common shares priced at $310 each.The offering comprised roughly 9.7 million common shares, with the underwriters fully exercising their option to purchase an additional 1.5 million shares.Celestica said it expects to use the net proceeds for working capital, investments in capital expenditures and other general corporate purposes.Price: $317.60, Change: $+3.07, Percent Change: +0.98%

$CLS